Navigation Links
New AERIUS Cell Phones Direct Microwave Signals Away from Users
Date:12/2/2009

Revolutionary new cell phones that direct microwave signal transmissions away from users will be available in early 2010 from Aerius International Ltd.

(PRWEB) December 2, 2009 -- Revolutionary new cell phones that direct microwave signal transmissions away from users will be available in early 2010 from Aerius International Ltd. The technology was recently honored with a Green Technology Award in wireless communication from Frost & Sullivan.

Cell phones use microwaves to communicate and according to Bill Luxon, Aerius CEO, "50% or more of those microwaves are absorbed by users. FCC tests show Aerius technology equipped phones eliminated 99.4% of cell phone microwaves absorbed by users below the US limit of 1.6 W/Kg."

Tests by T-Mobile USA and Rogers Wireless in Canada also show Aerius equipped phones increased signals available to networks 100% to 300%, which according to Joe Davis, Aerius VP Manufacturing, "would reduce dropped calls up to 60%. Another benefit is 2 to 4 more hours of battery life," said Davis.

According to Frost & Sullivan’s Green Technology award, widespread deployment of Aerius phones would save carriers up to 5 tons of carbon dioxide emissions per cell site per year, an added benefit for carrier profitability and the world’s environment.

"Because Aerius virtually eliminates SAR, or the specific absorption rate of cell phone radiation by users, it virtually eliminates health risks associated with long-term use of wireless phones recently reported by the World Health Organization and others, allowing everyone to use their phones worry-free," said Luxon.

"To benefit consumers worldwide independent carrier and lab test reports regarding Aerius phone performance have been posted in multiple languages on the Aerius website, goaerius.com," reported Chuck Closterman, Aerius VP Inter
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Cell Phones Put Traffic on Hold
2. Report Urges More Research Into Cell Phones
3. VIDEO from Medialink and Siemens: Doctors Trade in their Stethoscopes for Microphones
4. Carnegie Mellon study shows just listening to cell phones significantly impairs drivers
5. Kids With Cell Phones Not as Safe Crossing Streets
6. Verizon Wireless Customers Can Now Get Medication Information and Dosing Reminders with the Pill Phone Application on Their Phones
7. Iridium(R) Satellite, ProtectingAmerica.org and the American Red Cross Partner to Educate First Responders on Importance of Testing Satellite Phones
8. Anthem Blue Cross and Blue Shield in Connecticut Introduces Industrys First Electronic Tool to Help Members Search In-Network Doctors and Hospitals; Transparency Tool to Enable Searches Via Web-Enabled Cell Phones or Hand-Held Devices
9. Talking up a new role for cell phones in telemedicine
10. Mobile Phones: More Dangerous Than Smoking
11. No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... The Triumph Modular, ... practices, consumer education, resource library, floor plans, educational blog and wide use of ... offers regular posts with valuable links to useful reports by industry experts. Comments ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... announces the Lost and Found, a breakthrough technological invention. It is a ... for the consumer electronic industry reached a record high of $211.3 billion in ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Morristown Medical Center, ... Jersey, and one of the first five hospitals in the nation, to implant the ... patients on July 23, and all are in good condition. , The CoreValve® Evolut® ...
(Date:7/28/2015)... ... July 28, 2015 , ... DuPont leaders today ... Ethiopia to learn more about the impact of U.S. collaborations with local partners ... on accelerating agricultural development as an engine of broad-based economic growth in the ...
(Date:7/28/2015)... ... 2015 , ... Women in Technology (WIT), the premier organization contributing to the ... has selected Lisa Dezzutti, CEO and president at Market Connections, Inc. as the organization’s ... this organization that empowers women to thrive and excel in the technology field. In ...
Breaking Medicine News(10 mins):Health News:Triumph Modular Launches Refreshed Modular Building Industry Website 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 4Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 5Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2
... , VANCOUVER, June 10 /PRNewswire-FirstCall/ - Response Biomedical Corporation ... Livleen Kaler has been appointed Vice President Finance & ... years of financial management experience in several industries. , ... the Board is pleased to recognize Livleen for her ...
... Trust Inc. (NYSE: CRE ) ("Care" or the ... dividend of $0.17 per share of common stock for the first ... to common shareholders of record on June 23, 2009. , ... Trust Inc. is a real estate investment and finance company investing ...
... One of Bucks County,s largest employers will create more than ... the help of a new state investment in an ongoing ... an $11.1 million grant, on behalf of the Doylestown Hospital, ... , , The funds will be used ...
... statement from the American Chemistry Council regarding papers ... including: "Bisphenol-A Exposure In Utero Leads to Epigenetic ... "Low-Dose Bisphenol A Promotes Arrhythmogenesis in the Female ... Belcher, PhD; and "Oral Exposure of Female Rhesus ...
... find similar results , WEDNESDAY, June 10 (HealthDay News) ... drugs after radiation therapy do better when the drug treatment ... six-month regimen, a European study has found. , The results ... in May, said Dr. Eric M. Horwitz, acting chairman of ...
... Metoclopramide, a drug approved in the U.S. for nausea, ... according to a large cohort study published in the June ... Medicine , "The Safety of Metoclopramide Use in the First ... June 11, 2009). According to the pediatrician and clinical ...
Cached Medicine News:Health News:Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer 2Health News:Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer 3Health News:Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer 4Health News:Care Investment Trust Inc. Announces Quarterly Dividend 2Health News:State to Invest $11.1 Million in Expansion of Doylestown Hospital 2Health News:Press Releases on BPA Studies By-Pass Scientific Process 2Health News:Longer Hormone Treatment May Improve Prostate Cancer Outlook 2Health News:Longer Hormone Treatment May Improve Prostate Cancer Outlook 3Health News:Off-label morning sickness drug deemed safe for fetuses -- Ben-Gurion U. researchers 2
(Date:7/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cng4gn/refurbished ) has announced the ... Global Forecasts to 2019" report to their offering. ... estimated to grow expected to reach $9.37 billion by ... 2019. Factors such as growing ... increasing privatization in the healthcare sector, and rising adoption ...
(Date:7/28/2015)... 28, 2015  PD-Rx Pharmaceuticals, Inc., a publicly ... has partnered with Dobson Technologies, a fully-integrated outsourced ... (IaaS) product. PD-Rx is an Application ... United States.  Using Dobson Technologies, IaaS solution will ... continuity, ensure regulatory compliance, and reduce operating expenses.  ...
(Date:7/28/2015)... , July 28, 2015  For many medical ... researchers, physicians and other inventors can be a constant ... is difficult, and successes are rare. A ... to change that. Medical Device Investments (MDI) ... from universities, hospitals and physicians. MDI develops, manufactures and ...
Breaking Medicine Technology:Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2PD-Rx Partners With Dobson Technologies 2Medical Device Investments To Become Center Of Excellence For The Commercialization Of Innovative Medical Technologies 2
... and TARRYTOWN, N.Y., Nov. 10, 2011 Sanofi ... and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ... Phase 2 study program in which patients with ... REGN727/SAR236553. REGN727/SAR236553 is a novel, high-affinity, ...
... NASHVILLE, Tenn., Nov. 9, 2011 Revenue ... Non-GAAP Adjusted EBITDA of $76.7 million, increased 15.3% over third ... of healthcare revenue and payment cycle management and clinical information ... ended September 30, 2011, as summarized below: (In millions, except ...
Cached Medicine Technology:Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 2Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 3Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 4Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 5Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 6Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 7Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 8Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia 9Emdeon Reports Third Quarter 2011 Results 2Emdeon Reports Third Quarter 2011 Results 3Emdeon Reports Third Quarter 2011 Results 4Emdeon Reports Third Quarter 2011 Results 5Emdeon Reports Third Quarter 2011 Results 6Emdeon Reports Third Quarter 2011 Results 7Emdeon Reports Third Quarter 2011 Results 8Emdeon Reports Third Quarter 2011 Results 9Emdeon Reports Third Quarter 2011 Results 10Emdeon Reports Third Quarter 2011 Results 11Emdeon Reports Third Quarter 2011 Results 12Emdeon Reports Third Quarter 2011 Results 13
Liquichek Therapeutic Drug Monitoring Control (TDM) is a liquid assayed control containing a comprehensive menu of therapeutic drugs, as well as many common ligands. Available in three levels....
Liquichek Serum Volatiles Control is a bilevel liquid control with assayed values for the most widely measured volatile compounds....
Liquichek Urinalysis Control is specifically designed for urine dipstick and microscopic testing. This control provides clear, visual positive and negative results, including hCG (pregnancy) and micr...
qUAntify Plus Control is a combination urine dipstick and microscopic control. The control is available in either 12 mL centrifuge tubes or 120 mL flip-top squeeze bottles....
Medicine Products: